Abstract

Get full access to this article
View all access options for this article.
References
1.
Cardoni
AA
. Risperidone: review and assessment of its role in the treatment of schizophrenia . Ann Pharmacother
1995 ; 29 : 610 –8 .
2.
Guze
BH
Baxter
LR
. Neuroleptic malignant syndrome . N Engl J Med
1985 ; 313 : 163 –5 .
3.
Webster
P
Wijeratne
C
. Risperidone-induced neuroleptic malignant syndrome . Lancet
1994 ; 344 : 1228 –9 .
4.
Raitasuo
V
Vataja
R
Elomaa
E
. Risperidone-induced neuroleptic malignant syndrome in young patient (letter) . Lancet
1994 ; 344 : 1705 .
5.Package insert. Risperdal (risperidone) . Titusville, NJ : Janssen Pharmaceutica , December 1994 .
